Antimicrobial Agents and Chemotherapy, May 1998, p. 1187-1194, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Department of Infectious Disease Research, Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285
Received 8 December 1997/Returned for modification 23 February 1998/Accepted 9 March 1998
The echinocandins are a family of cyclic lipopeptides with potent
antifungal activity. These compounds inhibit the synthesis of
-1,3-glucan in fungi. The new semisynthetic echinocandin LY303366 was derivatized to produce a photoactivatable cross-linking
echinocandin analog with antifungal activity. This analog was
radioiodinated and used as a probe in microsomal membrane preparations
of Candida albicans which contain glucan synthase activity.
The photoaffinity probe identified two major proteins of 40 and 18 kDa
in both membrane preparations. Labeling of these proteins was specific
in that it required irradiation with UV light and was effectively
competed against with unlabeled echinocandin analogs. In addition, the abilities of echinocandin analogs to compete with the photoaffinity probe correlated to their relative antifungal potencies and glucan synthase inhibition. The 40-kDa protein was isolated, and partial sequences were obtained from internal peptide fragments of the protein.
Analysis of the sequences of these internal peptides of the 40-kDa
protein revealed that it was a new protein not previously described as
being involved in glucan synthesis or the mode of action of
echinocandins.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |